vs
豪瑞（AMRZ）与直觉外科（ISRG）财务数据对比。点击上方公司名可切换其他公司
豪瑞的季度营收约是直觉外科的1.3倍（$3.7B vs $2.8B），直觉外科净利率更高（29.8% vs 14.8%，领先15.0%），直觉外科同比增速更快（23.0% vs 6.6%）
豪瑞是总部位于瑞士的全球领先建筑材料及骨料供应商，为豪瑞集团旗下核心业务板块。原公司于2015年7月10日与拉法基合并组建拉法基豪瑞，2021年正式更名为豪瑞集团，合并完成后豪瑞品牌仍在集团内正常运营。
直觉外科（Intuitive Surgical）是美国医疗科技企业，主打研发、生产及销售微创外科手术机器人产品，核心产品为达芬奇手术系统，可有效提升患者临床治疗效果。该公司为纳斯达克100、标普100及标普500指数成分股，截至2021年末全球达芬奇系统装机量达6730台，其中美国市场占4139台。
AMRZ vs ISRG — 直观对比
营收规模更大
AMRZ
是对方的1.3倍
$2.8B
营收增速更快
ISRG
高出16.3%
6.6%
净利率更高
ISRG
高出15.0%
14.8%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.7B | $2.8B |
| 净利润 | $545.0M | $826.0M |
| 毛利率 | 29.6% | 66.1% |
| 营业利润率 | 21.2% | — |
| 净利率 | 14.8% | 29.8% |
| 营收同比 | 6.6% | 23.0% |
| 净利润同比 | -1.4% | 17.4% |
| 每股收益（稀释后） | $0.98 | $2.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRZISRG
| Q1 26 | — | $2.8B | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | $3.7B | $2.5B | ||
| Q2 25 | $3.2B | $2.4B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | $3.4B | $2.0B | ||
| Q2 24 | $3.2B | $2.0B |
净利润AMRZISRG
| Q1 26 | — | $826.0M | ||
| Q4 25 | — | $794.8M | ||
| Q3 25 | $545.0M | $704.4M | ||
| Q2 25 | $429.0M | $658.4M | ||
| Q1 25 | — | $698.4M | ||
| Q4 24 | — | $685.7M | ||
| Q3 24 | $553.0M | $565.1M | ||
| Q2 24 | $474.0M | $526.9M |
毛利率AMRZISRG
| Q1 26 | — | 66.1% | ||
| Q4 25 | — | 66.4% | ||
| Q3 25 | 29.6% | 66.4% | ||
| Q2 25 | 30.0% | 66.3% | ||
| Q1 25 | — | 64.7% | ||
| Q4 24 | — | 68.0% | ||
| Q3 24 | 30.2% | 67.4% | ||
| Q2 24 | 30.2% | 68.3% |
营业利润率AMRZISRG
| Q1 26 | — | — | ||
| Q4 25 | — | 30.2% | ||
| Q3 25 | 21.2% | 30.3% | ||
| Q2 25 | 20.8% | 30.5% | ||
| Q1 25 | — | 25.7% | ||
| Q4 24 | — | 30.4% | ||
| Q3 24 | 24.5% | 28.3% | ||
| Q2 24 | 23.3% | 28.2% |
净利率AMRZISRG
| Q1 26 | — | 29.8% | ||
| Q4 25 | — | 27.7% | ||
| Q3 25 | 14.8% | 28.1% | ||
| Q2 25 | 13.3% | 27.0% | ||
| Q1 25 | — | 31.0% | ||
| Q4 24 | — | 28.4% | ||
| Q3 24 | 16.0% | 27.7% | ||
| Q2 24 | 14.6% | 26.2% |
每股收益（稀释后）AMRZISRG
| Q1 26 | — | $2.28 | ||
| Q4 25 | — | $2.19 | ||
| Q3 25 | $0.98 | $1.95 | ||
| Q2 25 | $0.78 | $1.81 | ||
| Q1 25 | — | $1.92 | ||
| Q4 24 | — | $1.89 | ||
| Q3 24 | $1.00 | $1.56 | ||
| Q2 24 | $0.86 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $826.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.9B | $17.6B |
| 总资产 | $24.0B | $20.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRZISRG
| Q1 26 | — | — | ||
| Q4 25 | — | $5.9B | ||
| Q3 25 | $826.0M | $4.9B | ||
| Q2 25 | $601.0M | $5.3B | ||
| Q1 25 | — | $4.5B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | — | $4.8B |
股东权益AMRZISRG
| Q1 26 | — | $17.6B | ||
| Q4 25 | — | $17.8B | ||
| Q3 25 | $12.9B | $16.9B | ||
| Q2 25 | $12.4B | $17.8B | ||
| Q1 25 | — | $17.1B | ||
| Q4 24 | — | $16.4B | ||
| Q3 24 | $9.8B | $15.6B | ||
| Q2 24 | $9.3B | $14.7B |
总资产AMRZISRG
| Q1 26 | — | $20.1B | ||
| Q4 25 | — | $20.5B | ||
| Q3 25 | $24.0B | $19.4B | ||
| Q2 25 | $23.8B | $20.2B | ||
| Q1 25 | — | $19.2B | ||
| Q4 24 | — | $18.7B | ||
| Q3 24 | — | $17.7B | ||
| Q2 24 | — | $16.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $854.0M | — |
| 自由现金流经营现金流 - 资本支出 | $669.0M | — |
| 自由现金流率自由现金流/营收 | 18.2% | — |
| 资本支出强度资本支出/营收 | 5.0% | — |
| 现金转化率经营现金流/净利润 | 1.57× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRZISRG
| Q1 26 | — | — | ||
| Q4 25 | — | $892.5M | ||
| Q3 25 | $854.0M | $841.0M | ||
| Q2 25 | — | $715.4M | ||
| Q1 25 | — | $581.6M | ||
| Q4 24 | — | $822.6M | ||
| Q3 24 | — | $706.5M | ||
| Q2 24 | — | $620.5M |
自由现金流AMRZISRG
| Q1 26 | — | — | ||
| Q4 25 | — | $730.0M | ||
| Q3 25 | $669.0M | $735.6M | ||
| Q2 25 | — | $560.1M | ||
| Q1 25 | — | $465.0M | ||
| Q4 24 | — | $510.6M | ||
| Q3 24 | — | $458.6M | ||
| Q2 24 | — | $311.1M |
自由现金流率AMRZISRG
| Q1 26 | — | — | ||
| Q4 25 | — | 25.5% | ||
| Q3 25 | 18.2% | 29.4% | ||
| Q2 25 | — | 23.0% | ||
| Q1 25 | — | 20.6% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | — | 22.5% | ||
| Q2 24 | — | 15.5% |
资本支出强度AMRZISRG
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | 5.0% | 4.2% | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | — | 5.2% | ||
| Q4 24 | — | 12.9% | ||
| Q3 24 | — | 12.2% | ||
| Q2 24 | — | 15.4% |
现金转化率AMRZISRG
| Q1 26 | — | — | ||
| Q4 25 | — | 1.12× | ||
| Q3 25 | 1.57× | 1.19× | ||
| Q2 25 | — | 1.09× | ||
| Q1 25 | — | 0.83× | ||
| Q4 24 | — | 1.20× | ||
| Q3 24 | — | 1.25× | ||
| Q2 24 | — | 1.18× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRZ
| Building Materials | $2.8B | 75% |
| Building Envelope | $901.0M | 25% |
| Equity Method Investee | $5.0M | 0% |
ISRG
| Instruments and accessories | $1.7B | 61% |
| Systems | $650.7M | 23% |
| Services | $433.7M | 16% |
